Study: 17% of HCV patients have contraindication to therapy

01/28/2013 | Medscape (free registration)

A study found 17.3% of patients with chronic hepatitis C had a contraindication to pegylated interferon and ribavirin therapy, but most were treatable or transient. Bipolar disorders, anemia and pregnancy were the most common contraindications, according to researchers from State University of New York in Buffalo. Those with contraindications tended to be white, younger, female, unmarried and covered by public insurance.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID